Sparta Systems Promotes William B. Gerraughty, Jr. to Chief Operating Officer
Sparta Systems, Inc., has promoted William B. Gerraughty, Jr., to the role of chief operating officer (COO). Gerraughty, who currently serves as chief financial officer (CFO), will assume the responsibility of overseeing the company’s day-to-day operations, provide strategic planning and resource allocation, and advise the CEO and management team on key planning issues and important business decisions. Gerraughty will continue to serve as CFO and manage the company’s legal and human resource departments.
Before Sparta Systems, Gerraughty served as CFO at two publicly traded companies, NMS Communications and Infinium Software. He also held a number of executive positions, including president, COO and CFO at Intellution, a software company serving the industrial automation markets. Gerraughty began his career at Coopers and Lybrand.
“William Gerraughty’s success in ensuring the financial health of Sparta Systems makes him a natural choice to oversee the company’s daily operation as we head into 2010,” said James E. McGowan, CEO, Sparta Systems. “I’m confident that with his unparalleled record of accomplishment and complete knowledge of the company’s inner workings, his promotion to COO will help position Sparta for continued growth in the coming year and beyond.”
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
